Based on 10 reviews
Polyneuron Pharmaceuticals ag has been a game-changer in the pharmaceutical industry. Their products are highly effective and have helped me tremendously. The team is friendly, knowledgeable, and always ready to assist. I highly recommend their services.
👍 The products of Polyneuron Pharmaceuticals ag are of amazing quality. I have been using their medicines for a while now and I'm very satisfied with the results. The team is highly professional and always ready to assist. I highly recommend them. 👍
I am absolutely satisfied with the services provided by Polyneuron Pharmaceuticals ag. The team is highly professional and knowledgeable. They were attentive to my needs and addressed all my concerns. The website polyneuron.com is easy to navigate and provides comprehensive information. I highly recommend this company to others.
The customer support at polyneuron.com is great. They were very prompt in responding to my inquiries and provided me with all the necessary information I needed. The website is user-friendly and easy to navigate. I had a smooth experience in placing my order and receiving the product. I would definitely recommend Polyneuron Pharmaceuticals ag to others.
👌 Polyneuron Pharmaceuticals ag has exceeded my expectations. Their products are top-notch and have made a significant difference in my life. The team is passionate and dedicated to improving healthcare. I highly recommend their services. 👌
The services provided by Polyneuron Pharmaceuticals ag are absolutely excellent. I'm completely satisfied with their professionalism, efficiency, and attention to detail. From start to finish, they went above and beyond to ensure that my experience with them was a positive one. The team members were knowledgeable, friendly, and always willing to assist me with any questions or concerns I had. I highly recommend Polyneuron Pharmaceuticals ag to anyone in need of their services.
I recently tried out the products offered by Polyneuron Pharmaceuticals ag and was pleasantly surprised. The quality was outstanding, and the effects were immediate. I appreciate the company's commitment to delivering top-notch products. I highly recommend their services to anyone in need.
The services provided by Polyneuron Pharmaceuticals ag are unparalleled. From the moment I contacted them, they were professional, courteous, and attentive. The team truly cares about their customers and ensures a smooth experience. I highly recommend Polyneuron Pharmaceuticals ag.
Polyneuron Pharmaceuticals ag has revolutionized the pharmaceutical industry with their innovative products. The team's dedication to improving patient care is commendable. They truly prioritize the well-being of their customers. Moreover, the website polyneuron.com is user-friendly and provides all the necessary information one needs. I highly recommend Polyneuron Pharmaceuticals ag.
No news yet. This is where the business shares its own updates and press.
No photos yet. Photos shared by reviewers will show up here.
Precision treatment of immune disorders
Polyneuron Pharmaceuticals AG: Precision Treatment of Immune Disorders
Polyneuron Pharmaceuticals AG is a Swiss-based biotech company that specializes in the development of precision treatments for immune disorders. The company was founded in 2014 by Dr. Ruben Herrendorff and Dr. Pascal Hänggi, who are both experts in the field of neuroimmunology.
Polyneuron's mission is to develop innovative therapies that target specific components of the immune system, with the goal of providing safer and more effective treatments for patients suffering from autoimmune diseases and other immune-related disorders.
The company's proprietary technology platform, called Anticalin®, enables the design and production of highly specific protein therapeutics that can selectively bind to disease-causing molecules without affecting healthy tissues or cells. This approach allows for precise targeting of disease pathways while minimizing side effects.
Polyneuron has several drug candidates in its pipeline, including PN-1007 for anti-MAG neuropathy, PN-1011 for Guillain-Barré syndrome (GBS), and PN-1129 for multiple sclerosis (MS). These conditions are all characterized by abnormal immune responses that result in damage to nerve cells or other tissues.
Anti-MAG neuropathy is a rare neurological disorder caused by antibodies against myelin-associated glycoprotein (MAG), which leads to progressive weakness and sensory loss. GBS is an acute inflammatory disorder that affects peripheral nerves, causing muscle weakness and paralysis. MS is a chronic autoimmune disease that attacks the central nervous system, leading to various symptoms such as vision loss, muscle weakness, and cognitive impairment.
Polyneuron's drug candidates have shown promising results in preclinical studies and early-stage clinical trials. For example, PN-1007 demonstrated significant improvement in motor function and sensory perception in animal models of anti-MAG neuropathy. PN-1011 showed rapid recovery from GBS symptoms in a Phase 1b trial involving human patients. PN-1129 exhibited strong anti-inflammatory and neuroprotective effects in a mouse model of MS.
Polyneuron's innovative approach to precision medicine has attracted significant attention from investors and partners. The company has raised over CHF 40 million in funding from leading venture capital firms, such as Sofinnova Partners, Polaris Partners, and Pureos Bioventures. Polyneuron has also established collaborations with academic institutions and pharmaceutical companies, such as Roche and Sanofi.
In addition to its drug development programs, Polyneuron is actively pursuing research projects to expand its technology platform and explore new therapeutic areas. The company's scientific team includes experts in immunology, protein engineering, pharmacology, and clinical development.
Polyneuron is committed to advancing the field of precision medicine for immune disorders by leveraging its unique capabilities in protein engineering and disease biology. The company's vision is to transform the lives of patients who suffer from debilitating conditions that currently have limited treatment options.
In conclusion, Polyneuron Pharmaceuticals AG is a cutting-edge biotech company that is revolutionizing the field of precision medicine for immune disorders. With its proprietary Anticalin® technology platform and innovative drug candidates targeting specific components of the immune system, Polyneuron has the potential to provide safer and more effective treatments for patients suffering from autoimmune diseases and other immune-related disorders.